Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Psoriatic Arthritis Excellence Forum Excellence Forum

Psoriatic Arthritis
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

psoriasis
Quiz
06/16/2023
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
The Psoriasis Epidemiology Screening Tool (PEST) can help identify patients with psoriasis at higher risk of developing psoriatic arthritis. Do you know the key indicator? Take our quiz to find out!
The Psoriasis Epidemiology...
06/16/2023
Rheumatology & Arthritis
injection
Quiz
05/10/2023
Both methotrexate and biologics have some burden associated with treatment, from side effects to dealing with insurance coverage. But which burdens are greatest for patients with psoriatic arthritis? Find out what Dr Alexis Ogdie discovered...
Both methotrexate and biologics have some burden associated with treatment, from side effects to dealing with insurance coverage. But which burdens are greatest for patients with psoriatic arthritis? Find out what Dr Alexis Ogdie discovered...
Both methotrexate and biologics...
05/10/2023
Rheumatology & Arthritis
woman writing on computer
Conference Coverage
04/11/2023
Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.
Data from the Psoriasis Epidemiology Screening Tool survey found that evaluation by a rheumatologist was beneficial in patient-driven psoriatic arthritis screening.
Data from the Psoriasis...
04/11/2023
Rheumatology & Arthritis
quiz
Quiz
04/05/2023
Alexis Ogdie, MD, surveyed patients with psoriasis with the Psoriasis Epidemiology Screening Tool (PEST), a 5-item questionnaire on body parts affected by psoriasis and musculoskeletal symptoms among patients. What percentage of these...
Alexis Ogdie, MD, surveyed patients with psoriasis with the Psoriasis Epidemiology Screening Tool (PEST), a 5-item questionnaire on body parts affected by psoriasis and musculoskeletal symptoms among patients. What percentage of these...
Alexis Ogdie, MD, surveyed...
04/05/2023
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
03/17/2023
Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.
Dr Ogdie, from the University of Pennsylvania, discusses the analysis of results from the KEEPsAKE trials of risankizumab regarding the association of clinical measures and patient-reported outcomes in psoriatic arthritis.
Dr Ogdie, from the University of...
03/17/2023
Rheumatology & Arthritis
Saakshi Khattri, MD
Conference Coverage
03/07/2023
Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.
Results from the KEEPsAKE 1 and 2 trials demonstrated the efficacy of risankizumab in achieving and maintaining resolution of dactylitis and enthesitis among patients with psoriatic arthritis.
Results from the KEEPsAKE 1 and...
03/07/2023
Rheumatology & Arthritis
Alexis Ogdie, MD
Conference Coverage
02/13/2023
Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...
Dr Ogdie, from the University of Pennsylvania, presented an abstract at ACR Convergence 2022 on research she and colleagues conducted highlighting the need to actively screen patients with psoriasis for their risk of developing psoriatic...
Dr Ogdie, from the University of...
02/13/2023
Rheumatology & Arthritis
Lihi Eder, MD
Conference Coverage
12/19/2022
Dr Eder and colleagues used data from Israeli health services to compare immune responses among patients with psoriatic arthritis and/or psoriasis and general population controls to COVID-19 vaccines.
Dr Eder and colleagues used data from Israeli health services to compare immune responses among patients with psoriatic arthritis and/or psoriasis and general population controls to COVID-19 vaccines.
Dr Eder and colleagues used data...
12/19/2022
Rheumatology & Arthritis
Alexis Ogdie
Conference Coverage
11/14/2022
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of Pennsylvania, reviews her poster presentation from ACR Convergence 2022 on response rates among patients treated with risankizumab based on the number of swollen and tender joints, from the KEEPsAKE 1 and 2...
Dr Ogdie, from the University of...
11/14/2022
Rheumatology & Arthritis
Kelly Gavigan, MPH
Conference Coverage
11/12/2022
Through a cross-sectional online survey, Dr Gavighan and colleagues sought to examine the views and attitudes of individuals with psoriatic arthritis about using a guided online wellness program to manage their disease.
Through a cross-sectional online survey, Dr Gavighan and colleagues sought to examine the views and attitudes of individuals with psoriatic arthritis about using a guided online wellness program to manage their disease.
Through a cross-sectional online...
11/12/2022
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement